NCT07218380 2026-03-06
FORAGER-2
Eli Lilly and Company
Phase 3 Recruiting
Clinical Trials
14 trialsNCT07000084 2026-03-04
GAIN-BCG
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT06960577 2026-02-23
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
AstraZeneca
Phase 3 Recruiting
NCT07097142 2026-02-02
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
NRG Oncology
Phase 3 Recruiting
NCT06703476 2026-01-27
A Study of Surgical Techniques During Cystectomy
Memorial Sloan Kettering Cancer Center
Phase 3 Recruiting
NCT06747455 2025-12-23
BCG for Therapeutic Use Phase â…¢ Clinical Trial
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Phase 3 Recruiting
NCT05726786 2025-12-09
INCyst
Centre Hospitalier Universitaire Vaudois
Phase 3 Recruiting
NCT07067749 2025-07-24
TEMPO-MIBC
University of Rome Tor Vergata
Phase 3 Recruiting
NCT04574960 2025-07-20
NAUTICAL
University Health Network, Toronto
Phase 3 Recruiting
NCT05037279 2025-02-20
EVER
Verity Pharmaceuticals Inc.
Phase 3 Recruiting
NCT06441110 2024-06-04
Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer
Fujian Medical University Union Hospital
Phase 3 Recruiting
NCT06241755 2024-02-05
Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
Chengdu CoenBiotech Co., Ltd
Phase 3 Recruiting
NCT03216525 2023-09-28
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
Brigham and Women's Hospital
Phase 3 Recruiting
NCT04947059 2022-01-26
GENSA
University of Thessaly
Phase 3 Recruiting